This protocol establishes a quantitative imaging workflow that features the application of confocal microscopy to monitor the selective localization of the fluorescent peptidyl ClpP inhibitor FAM-FAPAL-CMK (Carboxyfluorescein-FAPAL-chloromethyl ketone) into the mitochondria to target ClpP, and the subsequent morphological changes in mitochondria in intact cells caused by ClpP inhibition.